InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Serafini-Lamanna Tony, Vice-Président Exécutif, Diagnostics. Officer active across 1 companies, notably Meridian Bioscience INC. Aggregated, 6 filings have been recorded. The latest transaction was disclosed on 15 November 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
€39,3272,232 shares@ €17.6198100.0% of flow
Common Stock
SEC:0001127602-21-031113·
€39,3272,232 shares@ €17.61980.052% mcap50.0% of flow
Common Stock
SEC:0001127602-21-031113:0·
24,343 shares
Common Stock
SEC:0001127602-21-029300:0·
24,343 shares
Common Stock
SEC:0001127602-21-029300·
010,593 shares0
Common Stock
SEC:0001127602-21-028577·
010,593 shares0
Common Stock
SEC:0001127602-21-028577:0·
6 of 6 declarations
About Serafini-Lamanna Tony
Tony Serafini-Lamanna is Executive Vice President, Diagnostics at Meridian Bioscience Inc. In this role, he oversees diagnostics-related operations and contributes to product innovation. Tony brings valuable expertise in the life sciences sector, playing a key role in developing advanced diagnostic solutions. His leadership is essential in strengthening Meridian's position in the market.
